In this study, we propose a within-host model for HIV infection of CD4+ T-cells.The model includes immune response, immune impairment, and antiretroviral treatment.Two types of antiretroviral drugs (reverse transcriptase inhibitors (RTIs) and protease inhibitors (PIs)) are used within the model.Positivity and boundedness of solutions are verified.We present two equilibrium points which are infection-free and infected one.The basic reproduction number is calculated, and it becomes the threshold indicating the stability of each equilibrium point.When it is less than a unity, an infection-free equilibrium point is locally stable, whereas when it is greater than one an infected equilibrium point exists.Global stability of infection-free equilibrium point is obtained with some conditions.Further, we extend the model by applying optimal control problem in which both antiretroviral drugs becomes control variables.This is to minimize the HIV infection of CD4+ T-cells.Our numerical results demonstrate that RTIs drug alone could slightly reduces an HIV infection whereas the PIs drug alone manages to reduce the infection largely.However, a combination of both types of drugs gives the best result for eliminating HIV infection of CD4+ T-cells.
No takes yet. Share an insight, caveat, or question.
Viriyapong et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: